Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma()

PURPOSE: Although targeting angiogenesis with tyrosine kinase inhibitors (TKIs) has become standard of care in the treatment of clear cell renal cell carcinoma (RCC), resistance mechanism are not fully understood, and there is a need to develop new therapeutic options overcoming them. METHODS AND MA...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Oncol
Päätekijät: Jang, Jiryeon, Rath, Oliver, Schueler, Julia, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Choi, Han-Yong, Kwon, Ghee-Young, Park, Woong Yang, Lee, Jeeyun, Park, Se Hoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2017
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358930/
https://ncbi.nlm.nih.gov/pubmed/28325666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.016
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia